ACTIVE

Pharmaconsult

Export PDF

Financial year 2025 · Closed on 30/09/2025

Net result5,8 k €+167,5 %over 1 year
Gross margin75,9 k €-4,8 %over 1 year
Equity286,8 k €+2,1 %over 1 year
Workforce0,0 ETP-100,0 %over 1 year

Identity

Source · BCE/KBO

Pharmaconsult is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beringen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0508.581.589
Incorporation
19/12/2012
Legal form
Private limited company
Registered office
Heerbaan 232
3582 Beringen · FlandreSee on map
Contributed capital
20 460,00 €
Latest accounts
30/09/2025
Average workforce
0,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 12 filings

Trend over 11 financial years

20252024202320222020
Income statement
Gross margin75,9 k €79,8 k €163,2 k €231,3 k €153,2 k €
EBITDA75,3 k €72,7 k €121,3 k €158,7 k €90 k €
Operating result11,1 k €6,7 k €53,2 k €89 k €31,1 k €
Net result5,8 k €2,2 k €35,8 k €61,6 k €22 k €
Balance sheet
Equity286,8 k €281 k €278,8 k €243 k €135,5 k €
Total assets669,8 k €670,9 k €655 k €681,2 k €736,6 k €
Cash156,6 k €125,8 k €102,4 k €97,9 k €47 k €
Debts382,4 k €389,4 k €352,1 k €435,9 k €601,1 k €
Other
Workforce0,0 ETP1,0 ETP1,0 ETP1,7 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 9 ended

Active mandates

PHARMATOPIA

Director · since 14 décembre 2023 · 1002.022.767

Represented by Verbeeck Barbara

Active

Ended mandates

PHARMATOPIA

Director · since 14 décembre 2023 · 1002.022.767

Represented by Verbeeck BARBARA

Ended
SYNTAXXIS

Manager · since 01 octobre 2017 · 0500.716.473

Ended
Barbara Verbeeck

Manager · until 30 septembre 2017

Ended
Barbara Verbeeck

Manager

Ended

Other companies at this address

Heerbaan 232 3582 Beringen
CompanyCBE no.
PHARMATOPIA● Active
1002.022.767

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/03/202617/03/202515/12/202301/04/202330/03/202231/03/2021
General meeting20/03/202628/02/202501/12/202317/03/202318/03/202212/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202520/03/202623/03/2026DutchPDF
Abridged model30/09/202428/02/202517/03/2025DutchPDF
Abridged model30/09/202301/12/202315/12/2023DutchPDF
Abridged model30/09/202217/03/202301/04/2023DutchPDF
Abridged model30/09/202118/03/202230/03/2022DutchPDF
Micro model30/09/202012/03/202131/03/2021DutchPDF
Micro model30/09/201904/03/202006/03/2020DutchPDF
Abridged model30/09/201829/03/201902/04/2019DutchPDF
Abridged model30/09/201716/03/201820/03/2018DutchPDF
Abridged model30/09/201617/03/201723/03/2017DutchPDF
Abridged model30/09/201518/03/201629/03/2016DutchPDF
Abridged model30/09/201416/03/201517/03/2015DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 9 ended

Active mandates

PHARMATOPIA

Director · since 14 décembre 2023 · 1002.022.767

Represented by Verbeeck Barbara

Active

Ended mandates

PHARMATOPIA

Director · since 14 décembre 2023 · 1002.022.767

Represented by Verbeeck BARBARA

Ended
SYNTAXXIS

Manager · since 01 octobre 2017 · 0500.716.473

Ended
Barbara Verbeeck

Manager · until 30 septembre 2017

Ended
Barbara Verbeeck

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates10/05/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/05/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/11/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other21/12/2012
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20255,8 k €↑
  2. 2024
    Annual accounts 20242,2 k €↓
  3. 2023
    Annual accounts 202335,8 k €↓
  4. 2022
    Annual accounts 202261,6 k €↑
  5. 2020
    Annual accounts 202022 k €↑
  6. 2019
    Annual accounts 2019-1,1 k €↓
  7. 2018
    Annual accounts 20181,8 k €↓
  8. 2017
    Annual accounts 201727,1 k €↓
  9. 2016
    Annual accounts 201628,7 k €↓
  10. 2015
    Annual accounts 201534,9 k €↓
  11. 2014
    Annual accounts 201435,4 k €
  12. 19/12/2012
    IncorporationPrivate limited company